Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Biology of cardiac arrhythmias: ion channel protein trafficking.

Delisle BP, Anson BD, Rajamani S, January CT.

Circ Res. 2004 Jun 11;94(11):1418-28. Review.

2.

Rescue of mutated cardiac ion channels in inherited arrhythmia syndromes.

Balijepalli SY, Anderson CL, Lin EC, January CT.

J Cardiovasc Pharmacol. 2010 Aug;56(2):113-22. doi: 10.1097/FJC.0b013e3181dab014. Review.

PMID:
20224422
3.

hERG potassium channels and cardiac arrhythmia.

Sanguinetti MC, Tristani-Firouzi M.

Nature. 2006 Mar 23;440(7083):463-9. Review.

PMID:
16554806
4.
5.

Do defects in ion channel glycosylation set the stage for lethal cardiac arrhythmias?

Fozzard HA, Kyle JW.

Sci STKE. 2002 Apr 30;2002(130):pe19. Review.

PMID:
11983936
6.

Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes.

Meadows LS, Isom LL.

Cardiovasc Res. 2005 Aug 15;67(3):448-58. Review.

7.

Molecular basis of arrhythmias.

Shah M, Akar FG, Tomaselli GF.

Circulation. 2005 Oct 18;112(16):2517-29. Review.

8.

Disorders of cardiac repolarization: long QT and short QT syndromes.

Horie M, Itoh H.

Circ J. 2007;71 Suppl A:A50-3. Review.

9.

Ion channels, the QT interval, and arrhythmias.

Wilde AA, Veldkamp MW.

Pacing Clin Electrophysiol. 1997 Aug;20(8 Pt 2):2048-51. Review.

PMID:
9272506
10.

The molecular basis of cardiac arrhythmias in patients with cardiomyopathy.

Ji S, Cesario D, Valderrabano M, Shivkumar K.

Curr Heart Fail Rep. 2004 Sep;1(3):98-103. Review.

PMID:
16036032
11.

Role of pharmacotherapy in cardiac ion channelopathies.

El-Sherif N, Pedalino R, Himel H 4th.

Curr Vasc Pharmacol. 2009 Jul;7(3):358-66. Review.

PMID:
19601860
12.

Human ether-a-go-go related gene (hERG) K+ channels: function and dysfunction.

Perrin MJ, Subbiah RN, Vandenberg JI, Hill AP.

Prog Biophys Mol Biol. 2008 Oct-Nov;98(2-3):137-48. doi: 10.1016/j.pbiomolbio.2008.10.006. Review.

PMID:
19027781
13.

[HERG K+ channel, the target of anti-arrhythmias drugs].

Guan FY, Yang SJ.

Yao Xue Xue Bao. 2007 Jul;42(7):687-91. Review. Chinese.

PMID:
17882949
14.

HERG channel trafficking.

Ficker E, Dennis A, Kuryshev Y, Wible BA, Brown AM.

Novartis Found Symp. 2005;266:57-69; discussion 70-4, 95-9. Review.

PMID:
16050262
15.

[Electrocardiogram in channel disorders].

González-Hermosillo JA.

Arch Cardiol Mex. 2004 Jan-Mar;74 Suppl 1:S79-83. Review. Spanish.

PMID:
15216752
16.

Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview.

Smits JP, Blom MT, Wilde AA, Tan HL.

Expert Opin Pharmacother. 2008 Mar;9(4):537-49. doi: 10.1517/14656566.9.4.537. Review.

PMID:
18312156
17.

Is it time to include ion channel diseases among cardiomyopathies?

Corrado D, Basso C, Thiene G.

J Electrocardiol. 2005 Oct;38(4 Suppl):81-7. Review.

PMID:
16226080
18.

HERG trafficking and pharmacological rescue of LQTS-2 mutant channels.

Robertson GA, January CT.

Handb Exp Pharmacol. 2006;(171):349-55. Review.

PMID:
16610352
19.

Gating and assembly of heteromeric hERG1a/1b channels underlying I(Kr) in the heart.

Robertson GA, Jones EM, Wang J.

Novartis Found Symp. 2005;266:4-15; discussion 15-8, 44-5. Review.

PMID:
16050259
20.

Structural determinants of potassium channel blockade and drug-induced arrhythmias.

Wehrens XH.

Handb Exp Pharmacol. 2006;(171):123-57. Review.

PMID:
16610343
Items per page

Supplemental Content

Support Center